Continuing Medical Education Series
Advances and Updates in Urologic OncologyRegister for the Series
Join us for our virtual didactic lecture series on critical topics and innovations in genitourinary oncology.
Earn one AMA PRA Category 1 Credit(s)™ is available per session.
Led by Ashley E. Ross, MD, PhD, the conference takes place the third Thursday of the month following GU Oncology Conference at 5:30 pm CST. Dr. Ross is a surgeon-scientist at Northwestern University Feinberg School of Medicine and member of Robert H. Lurie Comprehensive Cancer Center at Northwestern University who specializes in urology and urologic oncology, and is a nationally recognized expert in prostate cancer.
Northwestern Medicine Radiation Oncologists, William Hartsell, MD, Nasir Mohammed, MD, MBA, Stephen Mihalcik, MD, PhD, and Adil Akthar, MD, discuss fractionation of radiation therapy treatment in prostate cancer.
Sean Sachdev, Assistant Professor of Radiation Oncology at the Feinberg School of Medicine at Northwestern University, discusses the use of radiation for the management of recurring prostate cancer.
David VanderWeele, MD, PhD, Assistant Professor of Medicine (Hematology and Oncology) at Northwestern University Feinberg School of Medicine, discusses the PI3K/AKT pathway and its role in cancer, PI3K/AKT pathway alterations in prostate cancer, and inhibitors of the pathway and recent clinical trial results.
Sarki Abdulkadir, MD, PhD, discusses his research on the MYC protein and its role in cancer treatment.
Alicia Morgans, MD, MPH, discusses management options for patients with metastatic hormone-sensitive prostate cancer.
Shilajit Kundu, MD and Joshua Meeks, MD, PhD, discuss practice changing articles in bladder cancer.
Ashley Ross, MD, PhD, reviews sub-total glad therapies for prostate cancer, including patient selection and considerations, treatment selection and outcomes.
Presented by the Polsky Urologic Cancer Institute at Northwestern Medicine, "Advances and Updates in Urologic Oncology" is a virtual didactic lecture series on critical topics and innovations in genitourinary oncology. In this video, Sia Daneshmand, MD, Professor of Urology and Director of Clinical Research at the University of Southern California, discusses the current management of testis cancer.
Adam Murphy, MD, MBS, MSCI, Assistant Professor of Urology, reviews factors that may influence minority recruitment and participation in clinical trials and presents strategies for increasing diversity in clinical trials.
David VanderWeele, MD, PhD, Assistant Professor of Medicine in Hematology/Oncology, reviews the clinical and translational GU oncology research presented during the 2021 ASCO annual meeting.
Drs. Edward Schaeffer and Matthew Allaway discuss tools for optimizing prostate biopsy to enhance detection of clinically significant cancer and strategies to reduce morbidity for patients undergoing prostate biopsy.
Shilajit Kundu, MD, Professor of Urology at Northwestern Medicine describes the physiologic and genetic link between gut inflammation and prostate cancer risk, and potential targets that may be used in mitigating risk of inflammation induced tumorigenesis of the prostate.
Ashley Ross, MD, Professor of Urology at Northwestern Medicine discusses treatment plans for recurring prostate cancer also called second-line or salvage treatment.
Ziho Lee, MD, Assistant Professor of Urology at Northwestern Medicine discuss the contemporary use of robotic assistance in the treatment of complications following urologic oncologic procedures.
Hatice Savas, MD, Assistant Professor of Radiology, discusses current PET radiotracers that are used in prostate cancer imaging and newly approved PSME PET tracers.
Sweeney Christopher, MBBS, Medical Oncologist at the Dana-Farber Cancer Institute and Professor of Medicine at Harvard Medical School describes treatment selections in metastatic hormone-sensitive prostate cancer (mHSPC).